Latest News

Lytix Biopharma announces changes in the Board of Directors

Oral presentation by Lytix Biopharma at Esmo 2019

Lytix Biopharma is featured in Finansavisen, talking about Iovance collaboration and funding

Lytix Biopharma announces a clinical collaboration agreement with Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)